These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5911101)

  • 1. Effect of frontal pole ablation on biogenic amine levels in the brain.
    Nielson HC
    Exp Neurol; 1966 Aug; 15(4):484-9. PubMed ID: 5911101
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor.
    Fahn S; Libsch LR; Cutler RW
    J Neurol Sci; 1971 Dec; 14(4):427-55. PubMed ID: 5125758
    [No Abstract]   [Full Text] [Related]  

  • 3. The association of lesion-induced reductions in brain monoamines with alterations in striatal carbohydrate metabolism.
    Hoffmann PC; Toon R; Kleinman J; Heller A
    J Neurochem; 1973 Jan; 20(1):69-80. PubMed ID: 4687208
    [No Abstract]   [Full Text] [Related]  

  • 4. Decrease of dopamine and 5-hydroxytryptamine after intracerebral application of 5,6-dihydroxytryptamine.
    Saner A; Pieri L; Moran J; Da Prada M; Pletscher A
    Brain Res; 1974 Aug; 76(1):109-17. PubMed ID: 4844098
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetic analysis of 3H-serotonin accumulation in four regions of rat brain after lesions in the medial forebrain bundle.
    Yunger LM; Harvey JA
    Life Sci; 1976 Jul; 19(1):105-15. PubMed ID: 940428
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine action and disorders of neurotransmitter balance.
    Birkmayer W; Birkmayer JD
    Gerontology; 1987; 33(3-4):168-71. PubMed ID: 3653699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders.
    Hornykiewicz O
    J Psychiatr Res; 1974; 11():249-53. PubMed ID: 4282386
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.
    Scatton B; Javoy-Agid F; Rouquier L; Dubois B; Agid Y
    Brain Res; 1983 Sep; 275(2):321-8. PubMed ID: 6626985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental findings and new aspects in extrapyramidal diseases].
    Birkmayer W
    Wien Z Nervenheilkd Grenzgeb; 1966; 23(1):128-39. PubMed ID: 4226878
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain amine concentrations after monoamine oxidase inhibitor administration.
    Jones AB; Pare CM; Nicholson WJ; Price K; Stacey RS
    Br Med J; 1972 Jan; 1(5791):17-9. PubMed ID: 5008339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical aspects of involuntary movements (author's transl)].
    Nakamura S; Kameyama M
    No To Shinkei; 1981 Dec; 33(12):1177-85. PubMed ID: 7034752
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neuraminergic conception of extrapyramidal syndromology].
    Levin SL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(2):293-9. PubMed ID: 139066
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neurochemical basis for pathological motor activity].
    Hole K
    Tidsskr Nor Laegeforen; 1974 Jan; 94(1):11-7. PubMed ID: 4362478
    [No Abstract]   [Full Text] [Related]  

  • 14. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
    Marsden CD
    Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.
    Price KS; Farley IJ; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1978; 19():293-300. PubMed ID: 696462
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of mazindol, a non-phenylethylamine anorexigenic agent, on biogenic amine levels and turnover rate.
    Carruba MO; Groppetti A; Mantegazza P; Vicentini L; Zambotti F
    Br J Pharmacol; 1976 Apr; 56(4):431-6. PubMed ID: 1260223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of prolonged lithium treatment on the synthesis rate and turnover of monoamines in brain regions of rats.
    Ho AK; Loh HH; Craves F; Hitzemann RJ; Gershon S
    Eur J Pharmacol; 1970 Apr; 10(1):72-8. PubMed ID: 5458987
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical implications of monoamine oxidase inhibition.
    Pare CM
    Adv Biochem Psychopharmacol; 1972; 5():441-4. PubMed ID: 5054212
    [No Abstract]   [Full Text] [Related]  

  • 19. [Motor and psychomotor activity of striatal monoamines].
    Poirier LJ; Bédard P; Larochelle L
    Laval Med; 1970 Sep; 41(7):894-6. PubMed ID: 4994702
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
    Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.